欢迎来到CSNpharm!产品仅用于科研!

400-920-2911 sales@csnpharm.cn

0

您的位置 : 首页  /  JAK/STAT Signaling  /  STAT  /  Napabucasin

CAS No.: 83280-65-3

Napabucasin Catalog No. CSN18451

Synonyms: BBI608

Napabucasin is a first-in-class cancer stemness inhibitor that targets STAT3.

规格 价格 促销价格 库存 数量
纯度 & 质量文件 批次:

靶点选择性

生物活性

  • 描述
  • 细胞研究
  • Cell Data
  • 更多
  • 动物研究
    剂量

    Mice: 40 mg/kg[3] (i.p.)

    给药途径

    i.p.

  • 临床研究
  • NCT号适应症或疾病临床期招募状态预计完成时间地点
    NCT02232646Urologic Malignancies ... more >> Renal Cell Carcinoma Urothelial Carcinoma Collapse <<Phase 2Withdrawn(Low feasibility)--
    NCT03416816NeoplasmsPhase 1RecruitingJune 2020United States, Indiana ... more >> Indiana University Health Melvin and Bren Simon Cancer Center Recruiting Indianapolis, Indiana, United States, 46202 United States, Michigan Karmos Cancer Center Recruiting Detroit, Michigan, United States, 48201 United States, Texas UT Heatlh San Antonio Recruiting San Antonio, Texas, United States, 78229 United States, Utah Utah Cancer Specialist Recruiting West Jordan, Utah, United States, 84088 Collapse <<
    NCT02347917Malignant Pleural Mesothelioma... more >> Non-Small Cell Lung Cancer Collapse <<Phase 1 Phase 2Completed-Japan ... more >> National Cancer Center Hospital East Chiba, Japan National Cancer Center Hospital Tokyo, Japan Collapse <<
  • 更多

实验方案

技术信息

CAS号 83280-65-3 储存条件
分子式 C14H8O4 运输 蓝冰
分子量 240.21 别名 BBI608
溶解度
DMSO10.0 mg/mL (41.6 mM)
WaterInsoluble
EthanolInsoluble
动物实验配方
5% DMSO+40% PEG 300+5% Tween 80+water1 mg/mL

大规格询价

号为必填项

姓名: 邮箱: 手机号:
留言:
   提交
联系
我们